Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission.
The decrease in HIV acquisition after circumcision suggests a role for the foreskin in HIV transmission. However, the mechanism leading to protection remains undefined. Using tissue explant cultures we found that Langerhans cells (LCs) in foreskin alter their cellular protein expression in response to external stimuli. Furthermore, we observe that upon treatment with TNF-alpha, tissue-resident LCs became activated and that stimulatory cytokines can specifically cause an influx of CD4+ T-cells into the epithelial layer. Importantly, both of these changes are significant in the inner, but not outer, foreskin. In addition, we find that LCs in the inner foreskin have increased ability to sample environmental proteins. These results suggest differences in permeability between the inner and outer foreskin and indicate that HIV target cells in the inner foreskin have increased interaction with external factors. This increased responsiveness and sampling provides novel insights into the underlying mechanism of how circumcision can decrease HIV transmission.
Fahrbach
K M
KM
Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Barry
S M
SM
Anderson
M R
MR
Hope
T J
TJ
D000328:Adult; D000943:Antigens, Differentiation / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D002944:Circumcision, Male; D016207:Cytokines / Q000494:pharmacology; D004139:Dinitrofluorobenzene / Q000494:pharmacology; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D052816:Foreskin / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006678:HIV / Q000276:immunology* / Q000472:pathogenicity; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007801:Langerhans Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D046509:Tissue Culture Techniques; D014774:Virulence / Q000276:immunology
D000943:Antigens, Differentiation; D016207:Cytokines; D004139:Dinitrofluorobenzene
J Clin Invest. 2008 Oct;118(10):3440-52
18776939
Lancet. 2007 Feb 24;369(9562):657-66
17321311
PLoS Med. 2005 Nov;2(11):e298
16231970
AIDS. 2004 Mar 5;18(4):615-9
15090766
J Intern Med. 2009 Jan;265(1):18-28
19093957
Am J Pathol. 1996 Jul;149(1):337-43
8686758
Lancet. 2008 Nov 29;372(9653):1881-1893
19012954
Blood. 1997 Aug 1;90(3):909-28
9242519
J Allergy Clin Immunol. 2006 Jan;117(1):163-8
16387601
Lancet. 2007 Feb 24;369(9562):643-56
17321310
PLoS One. 2008 May 21;3(5):e2230
18493617
Arch Dermatol. 2007 Oct;143(10):1352
17938363
J Allergy Clin Immunol. 2001 Nov;108(5):688-96
11692090
Arch Dermatol Res. 1997 Apr;289(5):277-84
9164638
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3652-6
8170963
J Virol. 2007 Jul;81(13):6858-68
17442711
J Exp Med. 2006 Dec 25;203(13):2841-52
17145958
J Exp Med. 1994 Oct 1;180(4):1263-72
7523569
Immunol Today. 2000 Sep;21(9):418-20
10953090
J Immunol. 2003 Nov 15;171(10):4965-8
14607889
AIDS. 2009 Jan 28;23(3):319-28
19114867
FASEB J. 1994 Oct;8(13):1055-60
7926371
J Immunol. 1993 May 1;150(9):3698-704
8473727
PLoS Med. 2007 Jul 24;4(7):e223
17676944
Eur J Immunol. 2008 Sep;38(9):2377-85
18792031
Nat Rev Microbiol. 2004 Jan;2(1):33-42
15035007
Immunology. 2010 Feb;129(2):186-96
19824915
Nature. 2009 Apr 23;458(7241):1034-8
19262509
J Neurovirol. 2005;11 Suppl 1:58-65
15960240
PLoS Pathog. 2009 Jan;5(1):e1000274
19165325
Immunol Res. 2003;28(2):93-107
14610287
Histochem J. 1992 Oct;24(10):697-716
1428996
Circ Res. 2006 Mar 3;98(4):524-31
16424368